Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-20

Clinical Trial Update: Rasagiline Rescue in Alzheimer's Disease Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating rasagiline as a rescue therapy in Alzheimer's disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RASAGILINE (rasagiline)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-10-20